Premium
Frontispiece: Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments
Author(s) -
Chellan Prinessa,
Sadler Peter J.
Publication year - 2020
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.202084061
Subject(s) - combinatorial chemistry , antimicrobial , chemistry , group 2 organometallic chemistry , pharmacology , nanotechnology , medicine , materials science , organic chemistry , molecule
There is an urgent need for new drugs to combat resistance to current chemotherapeutic treatments, especially anticancer and antimicrobial drugs. Design concepts based on the conjugation of active organic fragments are well‐known. In their Minireview on page 8676 ff., P. Chellan and P. J. Sadler highlight the use of organometallic fragments to modify organic drugs and illustrate the potential for introducing novel mechanisms of action and restoring the activity of organic drugs against which resistance has developed.